Looking at the expression of CD45RA on this T cell subpopulation, however, increased percentages of CD45RA- CD4+ FOXP3+ cells correlated with poor outcomes in HNSCC patients [7]. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.